摘要
本文就武汉协和医院近5年(1991～1995年)口服降血糖药的消耗量以DDDs·d^(-1)为单位进行了比较,并计算出各药消耗金额占口服降血糖药总金额的百分比.结果显示,格列齐特(达美康)、格列喹酮(糖适平)呈逐年上升,其中格列喹酮上升的幅度最大;两种药所消耗金额之和占总金额的70%以上;临床用药量动态分析表明格列齐特、格列喹酮、格列本脲(优降糖)为武汉协和医院主要的口服降血糖药.
The quantity of oral hypoglycemic agents consumed in our hospital was investigated. The results were compared by using DDDs/day as unit and the percentage of total amount of money for each category was calculated. The results showed that gliclazide and glurenorm increased year by year and glurenorm was on the top of the list of the drugs with largest increase of consumption. The amount of money for the two drugs accounted for 70% of the total. The comparative analysis revealed that gliclazide, glurenorm and glibenclamide were the main oral hypoglycemic agents in our hospital.
出处
《药物流行病学杂志》
CAS
1996年第2期105-108,共4页
Chinese Journal of Pharmacoepidemiology
关键词
降血糖药
日限定量
药物流行病学
药物利用
Oral hypoglycemic agent
Definite daily dose
Pharmarcoepidemiology
Drug utilization
